Beaumont Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Beaumont Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-673	Closed	-$336K	–	349
2020 Q4	$336K	Sell	673 -24	-3%	-$10.7K	0.03%	247
2020 Q3	$274K	Buy	697 +15	+2%	+$5.55K	0.03%	271
2020 Q2	$225K	Buy	+682	New	+$197K	0.02%	257
2019 Q3	–	Sell	-924	Closed	-$254K	–	280
2019 Q2	$254K	Buy	+924	New	+$228K	0.03%	211
2018 Q4	–	Sell	-865	Closed	-$216K	–	215
2018 Q3	$216K	Buy	+865	New	+$210K	0.02%	210

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Beaumont Financial Advisors's IDXX Position: Q1 2021 in Review

Beaumont Financial Advisors sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 673 shares — an estimated $336K sold.

Beaumont Financial Advisors first reported a position in IDXX in Q3 2018 and held it in 5 quarters. The position peaked at $336K in Q4 2020. 1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

Beaumont Financial Advisors reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
Beaumont Financial Advisors sold 673 Idexx Laboratories shares in Q1 2021, an estimated $336K.
Beaumont Financial Advisors first reported a position in Idexx Laboratories in Q3 2018 and held it in 5 quarters.
Beaumont Financial Advisors's Idexx Laboratories position peaked at $336K in Q4 2020.
1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Beaumont Financial Advisors's 13F filing for Q1 2021, filed 4 May 2021.